Shire (SHPG) Dividend Payout Ratio : 0.10 (As of Sep. 2018)

View and export this data going back to 1998. Start your Free Trial

What is Shire Dividend Payout Ratio?

Shire's dividend payout ratio for the months ended in Sep. 2018 was 0.10.

The historical rank and industry rank for Shire's Dividend Payout Ratio or its related term are showing as below:

SHPG' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0.07
Current: 0.07

During the past 13 years, the highest Dividend Payout Ratio of Shire was 0.07. The lowest was 0.00. And the median was 0.00.

SHPG's Dividend Payout Ratio is not ranked
in the Biotechnology industry.
Industry Median: 0.415 vs SHPG: 0.07

As of today (2024-04-26), the Dividend Yield % of Shire is 0.59%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Shire was 0.59%. The lowest was 0.00%. And the median was 0.00%.

Shire's Dividends per Share for the months ended in Sep. 2018 was $0.17.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Shire Dividend Payout Ratio Historical Data

The historical data trend for Shire's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Dividend Payout Ratio Chart

Shire Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dividend Payout Ratio

Get a 7-Day Free Trial

0.07

0.04

0.10

0.35

0.07

Shire Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Dividend Payout Ratio	Get a 7-Day Free Trial															0.09	-	0.50	-	0.10

Competitive Comparison of Shire's Dividend Payout Ratio

For the Biotechnology subindustry, Shire's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shire's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shire's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Shire's Dividend Payout Ratio falls into.

Shire Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Shire's Dividend Payout Ratio for the fiscal year that ended in Dec. 2017 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2017 )	/	EPS without NRI (A: Dec. 2017 )
	=	0.924	/	13.98
	=	0.07

Shire's Dividend Payout Ratio for the quarter that ended in Sep. 2018 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2018 )	/	EPS without NRI (Q: Sep. 2018 )
	=	0.168	/	1.74
	=	0.10

Shire (NAS:SHPG) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Shire Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Shire's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Shire (SHPG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.shire.com

Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.

Executives

James H Cavanaugh

director

265 HOTHORPE LANE, VILLANOVA PA 19085